Pivotal Phase 3 trial of Glycerol phenylbutyrate in patients with hepatic encephalopathy

Trial Profile

Pivotal Phase 3 trial of Glycerol phenylbutyrate in patients with hepatic encephalopathy

Planning
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2015

At a glance

  • Drugs Glycerol phenylbutyrate (Primary)
  • Indications Hepatic encephalopathy
  • Focus Therapeutic Use
  • Sponsors Hyperion Therapeutics
  • Most Recent Events

    • 12 Mar 2015 New trial record
    • 27 Feb 2015 According to a Hyperion Therapeutics media release, this trial is expected to begin in second half of 2015.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top